The global Monoclonal Antibodies Characterization Services market size is predicted to grow from US$ 36.3 million in 2025 to US$ 50 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.

Monoclonal antibody (mAb) characterization services are analytical services specifically   designed to evaluate the structural, functional, and biophysical properties   of mAbs. These services ensure the quality, efficacy, and safety of mAbs for   therapeutic, diagnostic, and research applications.

United States market for Monoclonal Antibodies Characterization Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Monoclonal Antibodies Characterization Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Monoclonal Antibodies Characterization Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Monoclonal Antibodies Characterization Services players cover Intertek, Creative Proteomics, Infinity Bio, Charles River, BioPharmaSpec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Monoclonal Antibodies Characterization Services Industry Forecast” looks at past sales and reviews total world Monoclonal Antibodies Characterization Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Monoclonal Antibodies Characterization Services sales for 2025 through 2031. With Monoclonal Antibodies Characterization Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monoclonal Antibodies Characterization Services industry.

This Insight Report provides a comprehensive analysis of the global Monoclonal Antibodies Characterization Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Monoclonal Antibodies Characterization Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monoclonal Antibodies Characterization Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monoclonal Antibodies Characterization Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monoclonal Antibodies Characterization Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Monoclonal Antibodies Characterization Services market by product type, application, key players and key regions and countries.

Segmentation by Type:

    ELISA (Enzyme-Linked Immunosorbent Assay)
    Flow Cytometry
    Other

Segmentation by Application:

    Basic Science
    Drug Development
    Other

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Intertek
    Creative Proteomics
    Infinity Bio
    Charles River
    BioPharmaSpec
    Abcepta
    Eurofins Scientific
    Rockland Immunochemicals
    Proteintech
    Aragen Life Sciences Ltd.